Rekah Pharmaceutical Industry Ltd. (REKA)
Market Closed
15 Oct, 03:25 PM
TASE TASE Primary 1,055. 00
ILA -17
-1.5858%
157.64M Market Cap
- P/E Ratio
- Div Yield
5,146 Volume
- Eps
1,072 ILA
Previous Close Want to track REKA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Rekah Pharmaceutical Industry Ltd. (REKA) Statistics
Valuation metrics
Market Cap 157.64M
Enterprise value 234.17M
Trailing P/E (ttm) -7.5
Forward P/E -
PEG ratio 0.28
Price/Sales (ttm) 0.39
Price/Book (mrq) 0.85
Enterprise Value/Revenue 0.77
Enterprise Value/EBITDA 9.98
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 2.15K
Average volume (90 days) 2.87K
Price summary
52-Week low 1,006
52-Week high 1,348
Beta -
50-Day moving average 1,088.45
200-Day moving average 1,099.35
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.05%
Operating margin -0.02%
Operational effectiveness
Return on assets -0.04%
Return on equity -0.11%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 26.64
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.39
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.63
Total debt (mrq) -
Total Debt/Equity (mrq) 0.87
Current ratio (mrq) 1.41%
Book value per share (mrq) 12.28
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
